Agony hemorrhoidal Support Tablet
Natural health product licensed in Canada
- Licence holder
- CANADIAN NEUTRICEUTICAL HEALTH INC.
- NPN or DIN-HM
- 80118703
- Status
- Active licence
- Licence date
- 17 May 2022
- Revision date
- Not provided
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bioflavonoïdes d'agrumes Source : Citrus aurantiifolia - Pelure (fruit) Potency : 10 % Flavonoids expressed as hesperidin | 500 mg | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus aurantiifolia - Pelure (fruit) Potency : 90 % Diosmin | Not specified | Not calculated |
Non-medicinal ingredients
Maltodextrine, Dioxyde de silicium, Phosphate dicalcique, Oxyde de fer jaune, Oxyde de fer (Fe2O3), Macrogol 6 000, Croscarmellose de sodium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 3 Comprimé | 2 Tous les jours |
| Adultes | Not specified | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce lower leg edema associated with mild-to moderate chronic venous disease. Helps to relieve signs and symptoms of mild-to-moderate chronic venous disease such as varicose and spider veins, pain in the legs, sensation of heaviness, sensation of swelling and functional discomfort. Helps to reduce signs and symptoms associated with hemorrhoids, such as anal discharge, bleeding, discomfort, inflammation (proctitis), itching (pruritus), pain, redness (erythema), sensation of needing to pass stools (tenesmus) and swelling (edema). Helps to reduce the duration, intensity and recurrence of acute hemorrhoidal episodes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80118703
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.